Convergenze SpA Societa Benefit

As of December 31, 2024, Convergenze SpA Societa Benefit carries a market capitalization of 12.68M, placing it among publicly traded companies globally. Its enterprise value stands at 17.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Convergenze SpA Societa Benefit's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2024, Convergenze SpA Societa Benefit has 7.37M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Convergenze SpA Societa Benefit maintains a current ratio of 0.70, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Convergenze SpA Societa Benefit's stock has declined approximately 19.79% over the past 52 weeks. The 50-day moving average sits at 1.64, while the 200-day moving average is 1.66.

As of December 31, 2024, Convergenze SpA Societa Benefit holds 597,412.00 in cash and equivalents against 5.32M in total debt, resulting in a net debt position of 4.72M. Total book value stands at 6.59M, with working capital of -2.90M providing operational flexibility.